About Claris Injectables
Claris Injectables is a Healthcare company based in Ahmedabad (India) founded in 2005, and was acquired by Baxter in July 2017. Developer of natural resource and energy projects in South Eastern Europe. The company has 66 employees. Its Indian entity Claris Limited reported revenue of ₹27.69 Cr. Its focus areas include Traditional Pharmaceuticals, Generics and Injectables.
Company details
Claris Injectables was founded in 2005 and is headquartered in Ahmedabad, India. Natural resource and energy projects in South Eastern Europe are developed through acquisition, exploration, and exploitation of sector opportunities. Gold and base metal properties are examined for potential, while additional acquisitions are pursued. Operations are conducted in compliance with environmental regulations, targeting sustainable practices in the sector.
- Headquarters Ahmedabad, India
- Employees 66
- Stage Acquired
- SectorsHealthcare
- Website clarisinj.com
- Social LinkedIn
- Acquired by Baxter (Jul 2017)
- Legal Name Claris Limited
- Date of Incorporation 29 Aug, 2013
- Jurisdiction Ellisbridge, Gujarat, India
Associated legal entities of Claris Injectables
Claris Injectables operates through Claris Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Claris Limited CIN U11102GJ2013PLC076631 | Active | 29 Aug 2013 | Ellisbridge, Gujarat | ₹27.7 Cr | 66 | 9 | View details |
Investors in Claris Injectables
Claris Injectables has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Baxter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biosciences, medication delivery, and renal products are developed and marketed. | 1931 | baxter.com | Deerfield, United States |
Investor details for Claris Injectables
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Claris Limited (Claris Injectables)
Claris Limited is the primary company behind Claris Injectables. The board of Claris Limited currently have 6 directors; the longest-serving is Arjun Sushilkumar Handa, appointed in 2018. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Arjun Sushilkumar Handa DIN 00159413 | Director | 18 Jun 2018 | 8 yrs 4 mo | Claris Limited |
| Milina Purnendu Bose DIN 02204540 | Director | 25 Mar 2019 | 7 yrs 6 mo | Claris Limited |
| Shyamsunder Kashiram Sharma DIN 07563680 | Whole-time director | 24 Feb 2021 | 5 yrs 7 mo | Claris Limited |
| Roopesh Madan DIN 00168347 | Director | 11 Jan 2024 | 2 yrs 9 mo | Claris Limited |
| Hardik Pankajkumar Dagli DIN 10616503 | CFO | 08 Oct 2024 | 2 yrs | Claris Limited |
| Amit Sureshkumar Sharma DIN 05103265 | Additional Director | 27 Nov 2024 | 1 yr 10 mo | Claris Limited |
Financials of Claris Injectables
Figures of Claris Limited, the primary company behind Claris Injectables, for FY 2025. Revenue was ₹27.69 Cr (-54% year on year). Net loss was -₹199 Cr (-720% margin). EBITDA was -₹89.84 Cr (-324% margin). Revenue has grown at a compounded annual rate of -27% over three years and -39% over five years.
- ₹27.69 CrRevenue · FY 2025 · -54% YoY
- -₹199 CrNet loss · -720% margin
- -₹89.84 CrEBITDA · -324% margin
- ₹102 CrPaid-up capital
- 66Employees (provident fund records)
- -27%Revenue CAGR, 3 years
- -39%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Claris Limited are on its company page.
Detailed financial statements for Claris Injectables
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Claris Injectables
2 dated milestones of Claris Injectables across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Claris Injectables is founded.
- Exit Acquired by Baxter.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Claris Injectables (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 5,180 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.21 B | 25,870 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Claris Injectables
Complete news archive for Claris Injectables
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Claris Injectables
Claris Injectables was founded in 2005.
Claris Injectables is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Claris Injectables has 66 employees.
The primary company behind Claris Injectables, Claris Limited, reported revenue of ₹27.69 Cr for FY 2025, down 54% year on year.
Claris Injectables was founded in 2005 and is headquartered in Ahmedabad, India. Natural resource and energy projects in South Eastern Europe are developed through acquisition, exploration, and exploitation of sector opportunities. Gold and base metal properties are examined for potential, while additional acquisitions are pursued. Operations are conducted in compliance with environmental regulations, targeting sustainable practices in the sector.
Claris Injectables has 1 investor. Key investors include Baxter.
Claris Injectables operates through Claris Limited.
Yes. Claris Injectables was acquired by Baxter in July 2017.
The legal entities of Claris Injectables currently have 8 directors, including Arjun Sushilkumar Handa, Roopesh Madan, Hardik Pankajkumar Dagli and others.